NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer

Figure 1

Relationships of ESTIMATEScore, StromalScore, and ImmuneScore with survival in CRC patients. Kaplan-Meier survival investigations of CRC patients suffering from low and high (a) ImmuneScores, (b) StromalScores, and (c) ESTIMATEScores.

(a)

(b)

(c)